Background and aims While cigarette smoking has declined over time, it is not known whether this decline has
INTRODUCTION
Cigarette smoking is a leading cause of death and disease around the world [1] and the leading preventable cause of death and disease in the United States, responsible for at least 480 000 deaths annually [2, 3] . Since the mid1960s, the prevalence of smoking has declined substantially in the United States and other countries [2, [4] [5] [6] . However, several vulnerable groups continue to report significantly higher prevalences of smoking [7, 8] . People with illicit substance use disorders (SUDs) may be one such group.
Illicit drug use has been increasing over the past decade and recent data suggest that 3.9% of US adults meet criteria for a past-year SUD, while 9.9% of US adults meet criteria for a lifetime SUD [9] . The prevalence of smoking is high among people with a range of SUDs [7, 9, 10] and SUDs are associated with increased difficulty quitting smoking [10, 11] . Further, smoking among people with SUDs is associated with greater risks of mortality (e.g. [12, 13] ). Although the prevalence of cigarette smoking has declined over time in the general adult US population, and there have been research and clinical efforts aimed at promoting smoking cessation among people with SUDs (e.g. [14, 15] ), whether or not the prevalence of smoking has changed among those with SUDs over time is unknown. Understanding the extent to which cigarette use is common among those who have SUDs is of critical importance in recognizing what groups may need heightened public health and clinical efforts to reduce smoking.
Globally, cannabis is the most widely used illicit drug [16] . Cannabis use disorders (CUDs) are the most prevalent SUDs in the United States and there is evidence that CUDs are increasing, although results to date are mixed [11, [17] [18] [19] [20] [21] [22] . Unlike other illicit drugs, cannabis use is undergoing a changing legalization picture in a number of countries. For example, in the United States, an increasing number of states are legalizing medical cannabis and legalizing or decriminalizing the possession of small amounts of cannabis [23] . A number of concerns have been raised, including the impacts of the changing legalization status of cannabis on cannabis use and harmful consequences (e.g. [24] [25] [26] . Based on the global use of cannabis and its changing legal status, it would be informative to estimate the smoking prevalence among people with CUDs separately from people with illicit SUDs.
The purpose of the current study was to examine changes in the prevalence of current cigarette smoking over time among people with SUDs compared to those without SUDs in the United States. The first aim of the study was to use recent data (2014) to estimate cigarette smoking prevalence among those with and without SUDs unadjusted and after adjusting for demographics. To assess whether the prevalence of smoking differs among those with CUDs versus other SUDs, smoking prevalence was estimated separately for all SUDs (with CUDs included), SUDs excluding CUDs and CUDs compared to those without these respective disorders. The second aim of the study was to estimate changes in the prevalence of cigarette smoking from 2002 to 2014 among those with all SUDs, SUDs excluding CUDs and CUDs compared to those without these respective disorders.
METHODS

Study population
Data for this study came from The National Survey on Drug Use and Health (NSDUH), which collects annual cross-sectional data in multi-stage representative probability samples of US male and female civilian noninstitutionalized people aged 12 years and older in each of the 50 states and the District of Columbia. Methods of the NSDUH are described in detail elsewhere [27] . For this study, data were extracted from the public data portal (http://www.icpsr.umich.edu/) for the years 2002 to 2014. Respondents who reported information on cigarette smoking and SUDs were included in each year's data. The data sets from each year were concatenated adding a variable for the survey year. The analytical sample for 2014 (i.e. aim 1 analyses) was n = 55 271 and the total analytical sample from 2002 to 2014 combined (i.e. aim 2 analyses) was n = 723 283.
Measures
Past-month current smoking
Current smoking was assessed in each annual survey and defined as having smoked at least 100 lifetime cigarettes and reporting smoking part or all of at least one cigarette during the past 30 days. Current daily smoking was defined as ever having smoked 100 or more cigarettes and reporting smoking on 30 of the past 30 days, while non-daily smoking was defined as ever having smoked 100 or more cigarettes and reporting smoking on 1-29 of the past 30 days.
Past-year illicit SUDs
Past-year SUDs (abuse or dependence) were assessed in each annual survey by computer-assisted interviewing instrumentation based on criteria from the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV [28] ). For these analyses, a respondent was classified as having any SUD if they met criteria for abuse or dependence for one or more of the following illicit drugs: cannabis, hallucinogens, inhalants, tranquilizers, cocaine, heroin, pain relievers, simulants and sedatives. For these analyses, a second SUD variable was created that included all drugs listed above except cannabis. A third variable was created for CUDs for respondents who met criteria for cannabis abuse or dependence. Detailed abuse and dependence criteria are described in the NSDUH 2014 Codebook Appendix D, Recoded Substance Dependence and Abuse Variable Documentation section [27] , and are summarized in the Supporting information, Table S1 .
Demographic characteristics
Demographic variables were categorized as follows: age (12-17 years as reference group, 18-25 years, 26-34 years, 35-49 years, 50 years or older), gender (male as reference group, female), race/ethnicity (non-Hispanic white as reference group, non-Hispanic black, Hispanic, non-Hispanic all other races or more than one race), total annual family income (less than $20 000 as reference group, $20 000-49 999, $50 000-74 999, $75 000 or more), education (less than high school as reference group, high school graduate, some college, college graduate, and aged 12-17 years) and marital status (married as reference, widowed, divorced or separated, never been married, aged 12-17 years).
Statistical analysis
First, to identify potential demographic covariates, logistic regressions tested the association between past-year SUDs (yes versus no), past-year SUDs excluding CUDs (yes versus no), past-year CUDs (yes versus no) and smoking status (current cigarette smoking versus all other categories, i.e. never smokers, former smokers, recent quitters defined as those who reported cigarette smoking in the past year but not in the past 30 days and respondents with missing information on past 30-day cigarette use) from 2002 to 2014 overall and separately by each level of each demographic variable, controlling for all other demographic and smoking variables. The adjusted prevalence of current smoking from 2002 to 2014 was calculated from the logistic regression using the average marginal prediction approach [29] , by past-year SUDs, past-year SUDs excluding CUDs and past-year CUDs and each demographic characteristic (i.e. age, gender, race/ethnicity, total annual family income, education, marital status). Differential associations were tested with additional logistic regression models, including two-way interactions between each SUD and each demographic variable. All models were adjusted mutually for all other demographic variables. These analyses showed that smoking prevalence differed by SUD status within age, gender, race/ethnicity, total annual family income, education and marital status (see Supporting information, Tables S2-S4). These variables were included as covariates in the adjusted analyses described below.
Secondly, to estimate cigarette smoking prevalence in 2014 by SUD status (aim 1), logistic regressions tested the association of past-year SUDs (yes versus no), past-year SUDs excluding CUDs (yes versus no), past-year CUDs (yes versus no) and smoking status (current cigarette smoking versus all other categories) unadjusted and adjusted for within age, gender, race/ethnicity, total annual family income, education and marital status in 2014. Unadjusted and adjusted prevalences of current smoking in 2014 were calculated from the logistic regression using the average marginal prediction approach [29] by past-year SUDs, past-year SUDs excluding CUDs and past-year CUDs.
Thirdly, to estimate cigarette smoking prevalence from 2002 to 2014 by SUD status (aim 2), the prevalence of current smoking and associated standard errors among the whole population and stratified by past-year SUDs, past-year SUDs excluding CUDs and past-year CUDs were calculated for each year from 2002 to 2014. Time trends in the prevalence of current smoking stratified by past-year SUDs, past-year SUDs excluding CUDs and past-year CUDs were tested using logistic regression, with continuous year as the predictor for the linear time trend.
These analyses were conducted twice: first with no covariates (unadjusted) and then while adjusting for age, gender, race/ethnicity, total annual family income, education and marital status. To determine whether there were differential time trends in current smoking by SUD or CUD status, additional logistic regressions were run that included the two-way interaction of year × past-year SUD, past-year SUD excluding CUD and past-year CUD versus their respective comparison group (i.e. no past-year SUD, no past-year SUD excluding CUD, no past-year CUD). In order to examine smoking prevalence more closely among people with SUDs excluding CUDs, time trend analyses were repeated for daily smoking and non-daily smoking separately while adjusting for covariates. As our analyses used data from 13 NSDUH years, we divided the survey weights by 13 to obtain nationally representative estimates.
All analyses were performed incorporating the NSDUH sampling weights and controlling for the complex clustered sampling using SAS-callable SUDAAN version 11.0.1 (RTI International, Research Triangle Park, NC, USA; http://www.rti.org/sudaan/), which used the Taylor series estimation methods to provide accurate standard errors.
RESULTS
Cigarette smoking prevalence in 2014 by SUD status
In 2014, the prevalence of smoking was 19.16% for the overall population. The odds of smoking for people with any SUD was more than five times higher than for people without a SUD [odds ratio (OR) = 5.62, 95% confidence interval (CI) = 4.98-6.35], and this difference remained significant after adjusting for demographics [adjusted OR (aOR) = 5.25, 95% CI = 4.47-6.17; see Table 1 ]. For people with SUDs excluding CUDs, the odds of smoking were more than 7.5 times greater than people without SUDs excluding CUDs (OR = 7.59, 95% CI = 6.33-9.09). This difference reduced slightly to 6.5 times greater after adjusting for demographics (aOR = 6.46, 95% CI = 5.18-8.07). When examining CUDs, the odds of current smoking for those with CUDs was 4.5 times greater than for those without CUDs (OR = 4.61, 95% CI = 3.95-5.38), and this difference remained the same after adjusting for demographics (aOR = 4.56, 95% CI = 3.75-5.55).
Cigarette smoking prevalence from 2002 to 2014 by SUD status
Any SUD (Table 2) From 2002 to 2014, the prevalence of smoking decreased significantly among people with and without SUDs in unadjusted models (Ps < 0.05). After adjusting for age, gender, income, race/ethnicity, education and marital status, however, this decrease was no longer significant among people with SUDs (P = 0.084). The decrease in smoking prevalence remained significant among people without SUDs (P < 0.001). The prevalence of smoking for people with SUDs was nearly three times greater than people without SUDs in every year of the study. The interaction of time × SUD group was significant in unadjusted analyses (P < 0.05), but did not retain significant after demographic covariates were included (P = 0.943), suggesting that the decline in smoking prevalence did not differ significantly for people with and without SUDs.
SUDs excluding CUDs ( Fig. 1 and Supporting information, Table S5 )
The prevalence of smoking increased significantly among people with SUDs after CUDs were excluded from the variable (P < 0.05). In contrast, the prevalence of smoking decreased significantly among people without SUDs excluding CUDs (P < 0.001). Both the increasing trend for people with SUDs excluding CUDs and the decreasing trend for people without SUDs excluding CUDs remained significant after adjusting for demographics (P < 0.05 and P < 0.001, respectively). The prevalence of smoking among people with SUDs excluding CUDs was more than three times greater than people without SUDs in every year of the study. The time × SUD group interaction was significant in unadjusted (P < 0.001) and adjusted (P = 0.001) analyses, indicating that the trend in smoking differed significantly for people with versus without SUDs excluding CUDs.
With regard to daily smoking, people with SUDs excluding CUDs demonstrated a significant increase in daily smoking prevalence over time (aOR = 1.025, 95% CI = 1.005-1.045, t = 2.505, P = 0.013) compared to a significant decrease in daily smoking prevalence over time for those without SUDs excluding CUDs (aOR = 0.984, 95% CI = 0.981-0.988, t = À9.296, P < 0.001). For non-daily smoking, people with SUDs excluding CUDs demonstrated no significant change in non-daily smoking prevalence over time (aOR = 1.015, 95% CI = 0.995-1.035, t = À1.479, P = 0.141), compared to a significant decrease in non-daily smoking prevalence over time for those without SUDs excluding CUDs (aOR = 0.990, 95% CI = 0.986-0.995, t = À4.098, P < 0.001). Fig. 2 and Supporting information, Table S6 ) Cigarette use decreased significantly over time among both those with and without CUDs (Ps < 0.001). Both trends Met criteria for past-year abuse or dependence one or more of the following illicit substances: hallucinogens, inhalants, tranquilizers, cocaine, heroin, pain relievers, simulants and sedatives. remained significant after accounting for demographics (Ps < 0.001). The prevalence of smoking for people with CUDs was just under three times greater than people without CUDs in every year of the study. The time × CUD group analysis was not significant in unadjusted analyses (P = 0.166) but was significant in adjusted analyses (P < 0.01), suggesting a greater decrease in smoking prevalence for people with CUDs compared to those without CUDs.
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1 The association of current smoking with past-year SUDs, SUDs excluding CUDs and CUDs in 2014 (NSDUH, aged 12+; n = 55
DISCUSSION
The current study examined changes in cigarette smoking prevalence in the US population from 2002 to 2014 among people with and without SUDs. Among people without SUDs, the prevalence of smoking decreased over time, consistent with previously reported overall population trends. A decrease in the prevalence of smoking was also observed among persons with any SUD. Interestingly, this trend differed when CUDs and other SUDs were examined separately. The prevalence of smoking decreased among people with CUDs, but increased among people with SUDs other than CUDs. Specifically, there was a significant increase in daily smoking and no change in non-daily smoking over time among people with SUDs other than CUDs. Even though the smoking prevalence decreased over time among people with CUDs, it is important to note that the prevalence of smoking remained significantly higher among people with CUDs relative to those without in every year of the study. In 2014, the prevalence of cigarette smoking was approximately three times higher among people with any SUD, SUDs excluding CUDs and CUDs than among people without these disorders. These findings highlight the dramatic and widening disparity in smoking among people with SUDs compared to those without SUDs. Public health and intervention efforts are needed to reduce the high smoking prevalence among people with SUDs, especially SUDs associated with illicit substances other than cannabis, for whom the prevalence of smoking has increased over time.
The prevalence of smoking among people in treatment for SUDs is extremely high [30] [31] [32] , and SUD treatment programs may offer an important opportunity for smoking cessation. Historically, smoking has been viewed as a normative behavior in drug treatment settings and has either been encouraged or not been seen as a target of intervention. For example, there may be concerns that quitting smoking would impact the course of SUD treatment negatively [33] , even though tobacco is known as a potential 'gateway' into use of other drugs (e.g. [34, 35] ). There is mounting evidence, however, to suggest that smoking is associated with poorer outcomes for those in SUD treatment and relapse to SUDs among those in recovery (e.g. [36, 37] ). Further, smoking abstinence does not appear to hinder SUD treatment outcomes and may, in fact, be associated with improved outcomes (e.g. [38] [39] [40] [41] [42] [43] [44] ). Our results extend this literature by showing that cigarette use is disproportionately common among those with SUDs, and this is a group among whom cigarette smoking is on the rise in stark contrast to the consistent declines in the general population.
The declines in smoking in the general US population have been attributed largely to public health tobacco control efforts [45, 46] . The current results highlight the need to develop both community-oriented and clinical tobacco control measures that will reach people with SUDs. There are several pharmacological and behavioral smoking treatments that improve abstinence outcomes in community smokers [47] . Few studies have tested the efficacy or effectiveness of smoking treatments for people with SUDs, but several studies have shown promising outcomes, especially with pharmacotherapy and contingency management (e.g. [14, [48] [49] [50] ; see also [51] ). More research is needed to determine which current and novel smoking treatments would best help people with SUDs to stop smoking. In addition, there were significant relationships between SUDs and smoking for all demographic subgroups (see Supporting information, Tables S2-S4) . Notably, ORs between SUD and smoking the among the youngest age group (aged [12] [13] [14] [15] [16] [17] were three to four times higher than in the older age groups. Directing additional targeted clinical and research attention towards subgroups such as adolescents, for whom the relationship between SUD and smoking appears to be particularly strong, may be needed in order to decrease the smoking prevalence among the most vulnerable groups.
While the number of SUD treatment programs offering smoking cessation services has increased over time [15] , research is needed to determine how SUD treatment programs can integrate smoking treatments into their service delivery most effectively. For example, it is important to increase engagement and 'buy-in' for smoking treatment among program personnel by reducing perceived barriers, increasing smoking treatment expertise and providing stop smoking support to staff [52] [53] [54] [55] . Further, the belief that it is more difficult for people in SUD treatment to quit smoking is associated with poorer quit outcomes for these patients [56, 57] . Therefore, it would be important to address barriers and selfdefeating beliefs about quitting smoking held by SUD patients [56, 58] . Having staff work with patients to integrate smoking cessation into treatment plans may be beneficial, as a recent study of 683 patients receiving SUD treatment found that participants who reported that quitting smoking was part of their treatment plan were more likely to quit smoking than participants without quitting as a goal [59] . People in SUD treatment report that the use of non-cigarette tobacco products and use of other tobacco products is associated with heavier cigarette smoking [60] ; thus, it will be important for programs to assess and address the use of alternative tobacco products (e.g. e-cigarettes) to improve tobacco treatment outcomes, especially as the use of noncigarette tobacco products are rising [61] .
The present study has several limitations. First, this study analyzed data from US adults; therefore, results may not be generalizable outside the United States. As other countries show a similar pattern to the United States of higher smoking prevalences among people with SUDs and other vulnerabilities (e.g. psychiatric disorders) compared to the general population (e.g. [8] ), these results may provide information relevant to other countries. Future studies that can examine these relationships in various countries will be informative in understanding whether these linkages are culture/society-specific. Secondly, cannabis was the only drug that could be examined separately from SUDs, due in part to small sample sizes for the other substances. It would be useful for data sets with larger numbers of people with SUDs to examine trends in smoking prevalence by specific illicit drugs other than cannabis. This information would allow us to provide a more targeted clinical and public health response towards the specific SUDs that demonstrate an increase in smoking prevalence. Relatedly, while it was beyond the scope of the current study to investigate differences between those with CUDs and those with other illicit SUDs (e.g. demographics, mental health variables), understanding factors associated with or influencing the observed increase in smoking among those with illicit SUDs could contribute to the development of more effective public health and clinical efforts for this population. Thirdly, the NSDUH includes annual cross-sectional data from the US population. Longitudinal data that follow the smoking behaviors of individuals with and without SUDs over time would be useful to learn about trajectories of smoking. Fourthly, data on smoking and drug use is based on self-report without biochemical confirmation. The reliance upon self-reported drug use may lead to under-reporting [62, 63] . Strengths of the study include the use of repeated annual data from a large nationally representative sample of the US population and the examination of CUDs separate from other SUDs.
In contrast to substantial declines in smoking in the general US population, the prevalence of daily cigarette smoking has increased significantly from 2002 to 2014 among people with illicit SUDs. This increase in smoking prevalence is specific to people with SUDs other than cannabis, and was significantly different from the decreasing trend for smoking prevalence for people without SUDs excluding CUDs. It is important to note that the prevalence of cigarette smoking remains multifold higher among those with any SUD, as well as those with CUDs, compared to people without SUDs and CUDs. Those with SUDs appear to be a neglected population in terms of tobacco control, as these efforts do not appear to have reached this growing segment of the population. Efforts to move tobacco control forward may need to consider novel intervention strategies and outreach for the increasing proportion of the US population with SUDs. Further, specific public health efforts to reach people with SUDs in the community who are not receiving treatment may be needed to provide education concerning the relationship between tobacco and drug use and treatment options. The potential benefits include an increased chance of remission from SUDs, sustained smoking abstinence and improved physical and mental health.
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